Nemaria, Kingston Lyster P.

HRN: 21-81-12  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2025
CEFUROXIME 1.5GM (VIAL)
07/09/2025
07/16/2025
IV
500mg
Q8hours
ARTI
Remove - Pending Acceptance
07/11/2025
CEFTRIAXONE 1G (VIAL)
07/11/2025
07/18/2025
IV DRIP
1.2g
Q24
Dengue Fever With Warning Signs;URTI
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: